|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
Our Challenge
With recent advances in the science of therapeutic discovery (e.g., genomics, proteomics, stem cell research and digital chemistry), positive leads are created more rapidly in the early pipeline easily jamming the downstream development pipeline. With three-quarters of your development budget spent on clinical testing, it is vital to manage these costs as it applies to your overall portfolio. Knowing when to continue with the clinical development process for a given therapeutic agent or device and when to stop is key to your survival and ultimate success.
With at least 41% of your clinical testing costs tied directly to patient recruitment, it's no wonder why maintaining a minimum recruitment rate has been a main indicator for a continue/kill decision. However, today, more than 80% of clinical trials have major patient recruitment delays. Current methods of finding patients, mostly a manual process, are slow, irregular and have not caught up to the requirements of today's modern therapeutic protocols. Screening and consenting candidates consistently can be extremely challenging, especially when:
Precision Recruiting For Targeted Therapeutics
Accélère provides the first commercial solution to use real-time health care information to perform fact-based candidate screening and enrollment in a HIPAA-compliant manner. Our patent-pending technology-based solution is surpassing traditional clinical research boundaries and not only increasing recruitment rates up to ten times, but more importantly, enabling research on indications that are not possible with today's traditional methods.
We allow clinicians and investigators to focus on patient care and therapeutic delivery, not on manually combing large archives of patient files, memorizing the growing number of complex protocols and keeping track of all the screening steps for each patient within an environment often supporting study-specific HIPAA governance procedures. We work with research sponsors and participating research centers to configure and operate our network of real-time recruitment systems to maximize the chances of positively impacting the lives of the targeted patient population.
Accélère's high technology recruitment solution finds patients for clinical studies based on continually mining a dynamic flow of health care information in a HIPAA-compliant and secure manner. Patient medical record information is gathered by our infrastructure in real-time from a variety of health care systems, including registration, laboratory and pharmacy.
Real-Time Recruitment Monitoring
We provide online access via our secured portal to monitor the recruitment progress of your clinical trials in real-time. We give you 100% transparency on the various recruitment metrics that our system gathers allowing you to decide which sites need more resources and which ones are not worth further investment. We can provide summary reports that indicate overall patient counts for each step of your screening process. You can also drill down and review progress by study, site, investigator and coordinator.
  Empower Your Organization
Our company and technology will work with your existing product development organization or outsourced clinical research organization (CRO). Our system and tools can be accessed via a standard browser. Our simple, easy-to-use web interfaces keeps training short, while our identity management architecture allows you to control user access on a site, study, enrollment step and data field level basis.
We Invest In Your Sites
We are in the process of establishing our infrastructure at internationally recognized medical research centers in order to offer the volumes and diversity of subjects required for today's studies. We are focused on active patient flow (e.g., new patients per week), not on the number of historical patients as do many similar services. We help you target patients that are currently under active care and can be approached through the appropriate investigator within minutes.
If you have already selected sites for an upcoming study that are not in our network, we will deploy our infrastructure during the pre-clinical planning phase as part of working with you. In that regard, we can accelerate your trial planning and site prioritization and selection as well as the eventual downstream screening, data collection, enrollment and status reporting.
Performance-Based Business Model
With our standard offering, besides a small configuration fee for implementing your protocol, you only pay us when our infrastructure delivers screened and enrolled patients. There is no required hardware or software to purchase.
|
Our system continuously scans these "live" patient records against your study-specific screening scenarios 24 hours per day, 365 days per year and pages the appropriate team member when a match is found. Once the page is acknowledged, our system guides them through the recruitment steps required by the study (e.g., verification of inclusion/exclusion) and the site (e.g., local HIPAA-compliant consent procedures) to ensure the best chances of securing each potential subject for enrollment. Access to our system can be done through any secure (HTTPS) browser session, including those found on popular wireless devices.